Shu-Han Chang
Papers
1
Total Citations
7
H-Index
1
About
Dr. Shu-Han Chang is a distinguished gynecologic oncologist whose research focuses on optimizing surgical outcomes for women with early-stage cervical cancer. Her work critically evaluates the comparative effectiveness of laparotomic versus minimally invasive radical hysterectomy, addressing a pivotal debate in oncologic surgery. Dr. Chang’s most-cited study, published in 2024, systematically analyzed clinical data to compare recurrence rates, survival outcomes, and perioperative complications between these approaches. This investigation has already garnered 7 citations, underscoring its timely relevance as surgeons worldwide seek evidence-based guidance on balancing oncologic safety with minimally invasive benefits. By providing rigorous comparative data, Dr. Chang’s research directly informs clinical decision-making, helping to refine surgical standards for early-stage cervical cancer. Her contributions are particularly impactful in an era where minimally invasive techniques are rapidly evolving, yet questions remain about their equivalence to traditional open surgery. Dr. Chang’s work exemplifies the integration of surgical innovation with patient-centered outcomes, making her a key voice in advancing gynecologic oncology practice. Her ongoing investigations continue to shape treatment paradigms, offering clearer pathways for clinicians navigating complex surgical choices.
Research Focus
Key Achievements
Top Papers
- 1